Fujifilm’s vendor-agnostic Pathology PACS solution Synapse® Pathology, streamlines case management through proprietary advances in image digitization and solution interoperability to accelerate pathology-report turnaround. The solution’s open, cloud-accessible architecture allows customers to select the instruments, AI tools, and systems required for their own pathology workflows and use cases, such as clinical diagnosis, research, tumor boards, etc. Synapse Pathology enables pathologists to view images and render diagnosis and collaborate instantly from anywhere so they never have to wait for glass again!
- Health Canada-cleared: one of the few pathology solutions with multiple scanners approved for primary diagnosis in Canada
- Open Architecture: use your preferred blend of laboratory and diagnostic technologies with confidence in full compatibility
- AI Platform: provides the framework for laboratories to build and test their own image analysis tools or easily deploy algorithms from dedicated vendors
- Synapse Pathology captures 2023 Technology Award: in the 7th annual MedTech Breakthrough Awards program, Fujifilm’s Synapse Pathology won the “Best New Technology Oncology Solution” award. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.
Synapse Pathology in a nutshell:
- Open architecture that addresses treatment delays – Synapse Pathology is the world’s only truly open, vendor-agnostic, end-to-end digital pathology solution.
- Smarter workflows that reduce costs – Synapse Pathology delivers the essential case allocation, real-time collaboration, and outsourcing functionality critical to reducing the time to diagnosis.
- Artificial intelligence platform that removes bottlenecks – Synapse Pathology provides the framework for laboratories to build and test their own image analysis tools or easily deploy algorithms from dedicated vendors.
- System interoperability that drives collaboration – Digital pathology requires extensive IT infrastructure and support. Fujifilm can customize the level of IT support according to your needs.
- Robust security against it vulnerabilities – Secure protected health information (PHI) and safeguard against data loss and breaches with cloud-ready Synapse Pathology.
The Synapse Pathology system includes:
- Desktop and Web Client application options
- Dedicated Histology Lab Technician QA/QC functionality
- The ability to view Clinical History, Gross Description, patient demographics, prior cases and attached images from other modalities on a single screen
- Multiple ways to collaborate and share (same time; 1:1 any time; many to many)
- Automated de-identification to protect PHI for specific users with various roles and permissions
- Dedicated Histology Lab Technician slide matching functionality
- Automated image co-registration (completed without user interaction)
- Automated tissue navigation with a single click (jump from biopsy to biopsy)
- Intelligent image pruning/deletion; and the ability for users with appropriate permissions to override rules-based deletion for selected cases
- Cytology (z-stacking) and fluorescent WSI viewing capabilities
Synapse Pathology can include a bi-directional integration with any AP-LIS as well as an interface with your PACS and/or VNA system.
The system also supports a feature to reduce DICOM file size by up to 25% for more cost-effective archiving.
Five challenges. One solution.
- Diagnosis and treatment delays: Pathologist workforce shortages combined with inefficient shipping logistics and risk of physical slide loss can adversely delay diagnoses and impact patient outcomes.
- Soaring costs: organizations face accelerating costs for securely digitizing and storing pathology images.
- Throughput bottlenecks: providers require intelligent solutions that improve workload visibility and streamline workflows to reduce the turnaround time for diagnosis.
- System incompatibility: legacy systems can hinder image accessibility resulting in delayed second opinions for critical cases.
- Security threats: phishing assaults, malware attacks, and IT vulnerabilities force providers to replace legacy systems with secure solutions that meet FDA requirements.
Synapse Pathology is the world’s only truly open, vendor-agnostic, end-to-end digital pathology solution.
- Benefit from one of the few-Health Canada cleared pathology solution for primary diagnosis with multiple scanners in Canada.
- Use your preferred blend of laboratory and diagnostic technologies with confidence in full compatibility.
- Draw on Fujifilm’s approved digital pathology partner program for integrations with leading ecosystem vendors.
- Reduce the overall cost of digitization by maximizing the value of prior and future investments in adjacent technologies.
Synapse Pathology allows you to leverage your existing investment in digital pathology while future-proofing the next investment you will make in equipment, AI tools, IT systems, and infrastructure.
One vendor, one solution – Fujifilm: Focused on Continuous Innovation
In 1936, we launched our healthcare business with X-ray film, and we haven’t stopped innovating since.
For more than 80 years, we’ve continued to transform ourselves so we can help healthcare organizations like yours make the world a healthier place. As the industry advances, we’ll continue adapting-finding new ways to apply our unique technologies to solve preeminent healthcare challenges.
We’ll never stop iterating and developing digital solutions that progress radiography, endoscopy, ultrasound systems, healthcare IT, pharmaceuticals, and regenerative medicine. The Synapse Enterprise Imaging portfolio demonstrates this commitment to continuous innovation.